© Drug Hunter Inc. 2018-2023
Home > “compound 27”
potent pan-PIM kinase inhibitor
oral PD and efficacy in xenograft model
from SBDD of prior lead
Bioorg. Med. Chem. Lett., Oct. 14, 2020
Sanofi, Waltham/Cambridge, MA
“compound 27” (Sanofi oral in vivo pan-PIM kinase inhibitor)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year